// App-Quantinova.ai

TCT-461 : 6 Month Outcomes of Transcatheter Annular Reduction Therapy (TART) with the ARTO™ System for Functional Mitral Regurgitation

Researchers

Presenter

  • Stephen G. Worthley

Principal Investigators

  • Andrejs Erglis

  • Simon Redwood

  • David Hildick-Smith

  • Tony Rafter

  • Alan Whelan

Medical Centers

  • Genesis Healthcare, Sydney, Victoria, Australia

  • St Thomas' Hospital, London, United Kingdom

  • Royal Sussex County Hospital, Brighton, United Kingdom

  • The Mount Hospital, Perth, Western Australia, Australia

  • The Wesley Hospital, Brisbane, Queensland, Australia

  • P. Stradins Clinical University Hospital, Riga, Latvia

Locations

  • Australia

  • United Kingdom

  • Latvia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Mitral valve regurgitation

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Arm

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved